This phase III trial uses the Decipher risk score to guide intensification (for higher Decipher gene risk) or de-intensification (for low Decipher gene risk) of treatment to better match therapies to an individual patient's cancer aggressiveness.…
- Investigator
- Brian H Ramnaraign
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- Male